Mautz D S, Nelson W L, Shen D D
Department of Medicinal Chemistry, University of Washington, Seattle 98195, USA.
Drug Metab Dispos. 1995 Apr;23(4):513-7.
Regioselective and stereoselective oxidations of pseudoracemic metoprolol, (R)-bufuralol, and (S)-bufuralol by microsomes of h2D6v2 cells--a human lymphoblastoma cell line transfected with a cytochrome P4502D6 expression system--were examined. The formation kinetics of O-demethylmetoprolol and alpha-hydroxymetoprolol were characterized in five different lots of the cDNA-expressed P4502D6. Comparison of the Vmax/KM values indicated that formation of the products from (R)-metoprolol was preferred. Although the favored regiomer overall was O-demethylmetoprolol, the regioselectivity for O-demethylation of metoprolol by the cDNA-expressed enzyme was several-fold less than that observed for the P4502D6 enzyme in human liver microsomes at 20 microM pseudoracematic metoprolol concentration. Oxidation of (R)-metoprolol produced more O-demethylmetoprolol than alpha-hydroxymetoprolol; however, for (S)-metoprolol-d2, a slight preference for alpha-hydroxylation was observed. The O-demethylation and alpha-hydroxylation of metoprolol were inhibited at low microM concentrations of (+/-)-verapamil, a known inhibitor of metoprolol oxidation. (R)- and (S)-Bufuralol were oxidized to their respective diastereomeric 1"-hydroxybufuralols by all 4 lots of h2D6v2 microsomal preparations. Diastereomeric (1'R)-hydroxybufuralols were formed in twice the amount as the hydroxylated diastereomers of (1'S)-products. Product stereoselectivity was observed for the (1'R,1"S)- and (1'S,1"R)-isomers. Although the observed enantioselectivity and diastereoselectivity of the bufuralol oxidation seem to be consistent with those previously reported for human liver microsomes, the regioselectivity of the metoprolol oxidations is unexpectedly low.
研究了人2D6v2细胞(一种转染了细胞色素P4502D6表达系统的人淋巴瘤细胞系)微粒体对伪消旋美托洛尔、(R)-布呋洛尔和(S)-布呋洛尔的区域选择性和立体选择性氧化。在五个不同批次的cDNA表达的P4502D6中表征了O-去甲基美托洛尔和α-羟基美托洛尔的生成动力学。Vmax/KM值的比较表明,(R)-美托洛尔生成产物的反应更占优势。尽管总体上更倾向的区域异构体是O-去甲基美托洛尔,但在20μM伪消旋美托洛尔浓度下,cDNA表达的酶对美托洛尔O-去甲基化的区域选择性比在人肝微粒体中观察到的P4502D6酶的区域选择性低几倍。(R)-美托洛尔氧化生成的O-去甲基美托洛尔比α-羟基美托洛尔多;然而,对于(S)-美托洛尔-d2,观察到对α-羟基化有轻微偏好。美托洛尔的O-去甲基化和α-羟基化在低 microM浓度的(±)-维拉帕米(一种已知的美托洛尔氧化抑制剂)作用下受到抑制。所有4批次的h2D6v2微粒体制剂都将(R)-和(S)-布呋洛尔氧化为各自的非对映体1"-羟基布呋洛尔。非对映体(1'R)-羟基布呋洛尔的生成量是(1'S)-产物羟基化非对映体的两倍。观察到(1'R,1"S)-和(1'S,1"R)-异构体的产物立体选择性。尽管观察到的布呋洛尔氧化的对映选择性和非对映选择性似乎与先前报道的人肝微粒体的一致,但美托洛尔氧化的区域选择性出乎意料地低。